New hope for MS walking problems: could a drug and therapy combo be the answer?
NCT ID NCT06136728
Summary
This study is testing if combining a medication that helps with walking (dalfampridine) and a physical therapy program works better for improving mobility in people with multiple sclerosis than either treatment by itself. Researchers will enroll 48 adults with MS who have trouble walking. They will compare the results of people who get both the drug and therapy to those who get only physical therapy to see which approach helps more.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
MGH Institute of Health Professions
RECRUITINGBoston, Massachusetts, 02129, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.